News (Updated September 26, 2010)

[Home]  [
Previous news]


Did doctors jumpstart the HIV pandemic?

Sep 25 2010

By Frederik Joelving

NEW YORK (Reuters Health) - Perhaps it wasn't sex workers and fast-growing cities that launched HIV onto its deadly global rampage, but well-meaning doctors using dirty needles in the first half of the 20th century.

While it's hard to know for sure today, more than 90 years after the virus emerged, two new studies hint that campaigns to eradicate tropical diseases in Africa might have helped HIV gain an early foothold among humans.

"This is sort of an example of good intentions gone wrong," said Dr. Thomas Strickland, an expert in infectious diseases at Baltimore 's University of Maryland , who was not involved in the research.

"They were saving lives. They just didn't know that they were also setting up the pandemic of HIV."

The virus jumped from chimps to humans -- morphing from simian immunodeficiency virus, or SIV, to human immunodeficiency virus -- in central Africa in the early 1920s.

Most likely, scientists speculate, a hunter got infected through a bite or a scratch as he prowled for bush meat and butchered it west of the Ubangi River in what is now the Democratic Republic of the Congo .

What is still a matter of debate is how a blood-borne disease infecting one or a few individuals in a remote area could ever spread to the more than 33 million people who were infected by 2008, and kill two million of them.

To try to answer that question, Dr. Jacques Pepin, of the Universite de Sherbrooke in Quebec , Canada , hopped on a plane to central Africa . His goal was to track the spread of less lethal viruses -- as proxies for HIV -- among villagers who remembered the colonial era.

For one of two studies published this month, Pepin's team knocked on doors in dozens of villages in the Central African Republic to find seniors who'd been exposed to the sleeping sickness epidemic that ravaged the area between 1936 and 1950.

They asked a bunch of questions of more than 900 villagers, including whether or not they'd been treated for sleeping sickness -- at the time a grueling, hard-to-forget series of injections, Pepin said.

The researchers also took blood samples. Because the villagers who first caught HIV would be long dead today, Pepin decided to use the less-deadly hepatitis C virus as well as another blood-borne virus (human T cell lymphotropic virus 1, or HTLV-1) as models for how HIV could have been inadvertently transmitted by the French colonial doctors treating sleeping sickness.

What they found was striking: if a person had been treated for the sleeping disease before 1951, the chances that he or she had been infected with hepatitis C tripled. And HTLV-1 showed a similar pattern.

"What happened is that for a long time, the needles and syringes used to administer the intravenous drugs were not single-use," Pepin told Reuters Health. "There were a lot of patients and not a lot of needles, so the sterilization of needles was not very efficient."

"If HIV was present in one of these patients 50 years ago, we can assume that they probably transmitted HIV," he said. "It is exactly like intravenous drug users who share needles."

According to Pepin, that would also explain why the number of people 65 years and older who'd been treated for sleeping sickness was six times lower than would be expected from historical data: the missing seniors could have died of AIDS, the immune system breakdown caused by HIV.

"Everybody now is getting infected from having sex," said Strickland, who wrote an editorial about the new findings, published in the journal Clinical Infectious Diseases.

"But that is not very good transmission. You can have heterosexual sex ten or fifteen times without getting infected. But if you get injected with a contaminated needle, the risk is much higher."

Pepin's other study shows that in Cameroon, a neighboring state that also used to be under French rule, massive outbreaks of hepatitis C in the first half of the 19th century were related to malaria treatment with the drug quinine.

More than half the hundreds of graying heads he rounded up had traces of an earlier hepatitis C infection in their blood.

"The most important mode of infection was the intravenous treatment of malaria," said Pepin. "If we put all of this together, it shows that there was a lot of transmission of different viruses through different interventions for tropical diseases."

"Probably HIV was transmitted as well," he argues.

But nobody is left to bear witness of what really happened, and not all scientists believe Pepin's explanation.

"It is a wonderful study on the hepatitis C virus," said Michael Worobey, a biologist at the University of Arizona in Tucson who studies the origins of HIV. "I'm not so convinced it should have been sold on the HIV/SIV angle."

His version of what happened follows the traditional line of argument among scientists: as colonial powers began building cities and railroads, they transformed former woodlands into densely populated towns rife with prostitution -- perfect hotbeds for blood-borne diseases.

Eventually an infected villager made his way to the city, setting off the HIV epidemic like a spark falling on a dry savanna.

"I think a train is a much better way to get a virus to a city than a needle," Worobey told Reuters Health.

He said the idea that doctors kicked off the HIV pandemic has been around for years. And while the new experiments are probably the first to test it, he added, they don't settle the question.

To Pepin, the two explanations aren't mutually exclusive. Dirty needles "played a substantial role that was probably as important as prostitution," he said.

Although single-use needles are now commonplace in most of the world, and unprotected sex is the major reason people get HIV, Pepin said some wisdom might still be gleaned from what he found.

"Hopefully it will make doctors a bit more prudent about novel medical interventions," he said.

 

19 pct of gay, bisexual men in U.S. cities have HIV

Sep 23 2010

wpe6.jpg (20165 bytes)CHICAGO (Reuters) - Nearly one in five gay and bisexual men in 21 major U.S. cities are infected with HIV, and nearly half of them do not know it, U.S. health officials said on Thursday.

Young men, and especially young black men, are least likely to know if they are infected with HIV, according to the U.S. Centers for Disease Control and Prevention.

"For young men who have sex with men - including young men of color who are least likely to know they may be infected - the future is truly on the line," Dr. Jonathan Mermin, director of CDC's Division of HIV/AIDS Prevention, said in a statement.

"It is critical that we reach these young men early in their lives with HIV prevention and testing services and continue to make these vital services available as they become older."

The study tested 8,153 men who have sex with men in 21 cities taking part in the 2008 National HIV Behavioral Surveillance System, which looked at the prevalence of the human immunodeficiency virus and awareness of HIV status among this group of men. HIV is the virus that causes AIDS.

They found that 28 percent of black men who have sex with men were infected with the HIV virus, compared with 18 percent of Hispanic men and 16 percent of white men.

The incidence of HIV in this group of men is strongly affected by education and income, the authors said, noting that the lower a person's socioeconomic status, they more likely he was to have HIV, CDC researchers reported in the CDC's weekly report on death and disease.

Age was also a factor in whether men know they are infected with HIV. Among those aged 18 to 29 who had HIV, 63 percent did not know it, compared with 37 percent for men aged 30 and older.

That is especially dangerous because the CDC estimates that most new sexually transmitted infections are passed along by people who do not know they are infected.

Mermin said the findings show HIV is still a serious problem in America , and called for a renewed national commitment efforts to protect the health of gay men.

The CDC recommends that gay and bisexual men of all ages get an HIV test each year, and men at highest risk -- those who have multiple sex partners or use drugs during sex -- get tested every three to six months.

"We need to increase access to HIV testing so that more MSM (men who have sex with men) know their status, and we all must bring new energy, new approaches, and new champions to the fight against HIV among men who have sex with men," Dr. Kevin Fenton, director of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, said in a statement.

(Editing by David Storey)

 

Long-awaited microbicide gel faces funding shortfall

Carol Campbell

24 September 2010 | EN

AIDS_tenofovir_applicator_caprisa_140.jpg

More funds needed to get this into the hands of women

Caprisa

[ OUDTSHOORN , SOUTH AFRICA ] South African scientists are in New York this week trying to secure funding for the final trials of a vaginal gel that could save millions of lives by giving women the chance to protect themselves against HIV/AIDS.

The microbicide gel, containing the antiretroviral agent tenofovir, passed phase III clinical trials in June, and the success was announced at the XVIII International AIDS Conference in Vienna in July.

But efforts last month to drum up funding for two final trials have so far produced promises of only US$58 million, much less than the US$100 million that the researchers want.

Salim Abdool Karim, a scientist at the Centre for the Aids Programme of Research in South Africa (CAPRISA) who led a study of the gel with his wife, Quarraisha Abdool Karim, said the money is needed to pay for support studies and product licensing.

The CAPRISA 004 trial, which found that tenofovir gel was at least 39 per cent effective in preventing HIV infection when it was applied before and after sex, was conducted in South Africa 's KwaZulu-Natal province, which has one of the world's highest HIV infection rates. A woman can apply the gel even if her partner refuses to use a condom.

So far, the South African Department of Science and Technology has offered US$13.5 million, USAID in Washington is giving US$18.5 million, USAID in South Africa US$19 million and the United Kingdom 's Medical Research Council (MRC) about US$7 million.

The funders made their offers at an August meeting in Johannesburg of the global HIV/AIDS community, held to plan the research needed to complete studies on the gel.  

"I was very disappointed after the meeting," said Karim. "I expected to walk out with all the money we needed to take this project to the next level."

He is now meeting other potential funders in the United States and approaching donors in Sweden .

"If we still do not have enough we will ask Australia and Japan ," he said.

The UK Department for International Development (DFID), once a major supporter of microbicide research, has declined to fund the work, said Karim.

"That was very disappointing as I had expected it would be interested in a project like this," he added.

A DFID spokesperson said the department partially funds the MRC, which is spending money on the trials. Further, all DFID programmes are under review and it cannot presently make new funding decisions.

Meanwhile, the European and Developing Countries Clinical Trials Partnership (EDCTP) said it would first have to consult member states. The Gates Foundation also attended the August meeting but has not offered any funding so far, said Karim. The foundation did not respond to SciDev.Net inquiries.


[Home]  [Previous news]